PTSD — Helping Families Help Veterans With PTSD and Alcohol Abuse: An RCT of VA-CRAFT
Citation(s)
Erbes CR, Stillman JR, Wieling E, Bera W, Leskela J A pilot examination of the use of narrative therapy with individuals diagnosed with PTSD. J Trauma Stress. 2014 Dec;27(6):730-3. doi: 10.1002/jts.21966. Epub 2014 Nov 10.
Kuhn ER, Landes S Mental and Behavioral Health Apps for Service Members, Veterans, and Providers. Society for Media Psychology & Technology: The Amplifier. 2013 Apr 1; Spring/Summer(2013):8-10.
Renshaw KD, Campbell SB, Meis L, Erbes C Gender differences in the associations of PTSD symptom clusters with relationship distress in U.S. Vietnam veterans and their partners. J Trauma Stress. 2014 Jun;27(3):283-90. doi: 10.1002/jts.21916. Epub 2014 May
Tran T, Kuhn ER, Walser R, Drescher K The relationship between religiosity, PTSD, and depressive symptoms in veterans in PTSD residential treatment. Journal of psychology and theology. 2012 Oct 1; 40(Winter 2012):313-322.
Whealin JM, Kuhn E, Pietrzak RH Applying behavior change theory to technology promoting veteran mental health care seeking. Psychol Serv. 2014 Nov;11(4):486-94. doi: 10.1037/a0037232.
Helping Families Help Veterans With PTSD and Alcohol Abuse: An RCT of VA-CRAFT
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
